Agree.
With the prior announcement falling prior to the halt, has to looking positive.
Appointment of Dr Tony Keating as Executive Director & Resignation of Dr Tom Young Highlights: • Appointment of Dr Tony Keating as part time Executive Director, effective 29 July 2024
•Dr Keating brings extensive experience as a healthcare executive, having co-founded ResApp Health and led it through commercialisation, culminating in a $180m acquisition by global biopharmaceutical company Pfizer in 2022
• Along with his track record in commercialising AI-based digital health technology, Dr Keating brings advanced knowledge of the US regulatory landscape and strong networks in the global healthcare industry
• Appointment strengthens the composition of the Board ahead of pending results of TRI’s comprehensive Phase 2 SAMDE study for TrivarX’s proprietary MEB-001 algorithm which assists with the effective screening of a current Major Depressive Episode (cMDE)
• Resignation of Dr Thomas Young as Non-Executive Director, effective 29 July 2024
- Forums
- ASX - By Stock
- TRI
- Ann: Trading Halt
Ann: Trading Halt, page-4
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $10.05M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.515K | 159.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 46350 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 287829 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 46237 | 0.022 |
1 | 175268 | 0.021 |
3 | 650000 | 0.020 |
2 | 1000000 | 0.019 |
3 | 1750000 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 348435 | 3 |
0.026 | 330000 | 2 |
0.027 | 500000 | 1 |
0.030 | 236823 | 2 |
0.031 | 300000 | 1 |
Last trade - 11.52am 03/09/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |